Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × Doxorubicin × Clear all

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 24 Breast Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Neoplasms 13 Lymphoma 12 Ovarian Neoplasms 11 Burkitt Lymphoma 11 Neoplasm Metastasis 9 Lymphoma, Non-Hodgkin 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Neuroblastoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, T-Cell, Peripheral 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Follicular 5 Lymphoma, B-Cell 5 Leukemia 5 Hodgkin Disease 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Small Cell Lung Carcinoma 4 Prostatic Neoplasms 4 Multiple Myeloma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 HIV Infections 4 Fallopian Tube Neoplasms 4 Carcinoma, Hepatocellular 4 Acquired Immunodeficiency Syndrome 4 Sarcoma, Kaposi 3

Interventions

Temozolomide 39 Radiotherapy 13 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Surgical Procedures, Operative 7 Irinotecan 7 Radiation 6 Carboplatin 6 ribociclib 5 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Imiquimod 5 Flucytosine 5 Filgrastim 5 Erlotinib Hydrochloride 5 Carmustine 5 Aminolevulinic Acid 5 vandetanib 4 sargramostim 4 Topotecan 4 O(6)-benzylguanine 4 Imatinib Mesylate 4 IL13-PE38 4 Etoposide 4 Cyclophosphamide 4 Craniotomy 4 vocimagene amiretrorepvec 3 lentiviral minigene vaccine of COVID-19 coronavirus 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02861222 2016-08-10

MYOCET

Central Hospital, Nancy, France

Phase 1 Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡